Terms: = Lymphoma AND RARA, RAR, 5914, ENSG00000131759, NR1B1 AND Treatment
69 results:
1. Development of Bexarotene Analogs for Treating Cutaneous T-Cell lymphomas.
Warda A; Staniszewski LJP; Sabir Z; Livingston S; Sausedo M; Reshi S; Ron E; Applegate MT; Haddad D; Khamisi M; Marshall PA; Wagner CE; Jurutka PW
Cells; 2023 Nov; 12(21):. PubMed ID: 37947652
[TBL] [Abstract] [Full Text] [Related]
2. Use of tamibarotene, a potent and selective rarα agonist, in combination with azacitidine in patients with relapsed and refractory AML with
Stein EM; de Botton S; Cluzeau T; Pigneux A; Liesveld JL; Cook RJ; Rousselot P; Rizzieri DA; Braun T; Roboz GJ; Lebon D; Heiblig M; Baker K; Volkert A; Paul S; Rajagopal N; Roth DA; Kelly M; Peterlin P
Leuk Lymphoma; 2023 Dec; 64(12):1992-2001. PubMed ID: 37571998
[TBL] [Abstract] [Full Text] [Related]
3. An Isochroman Analog of CD3254 and Allyl-, Isochroman-Analogs of NEt-TMN Prove to Be More Potent Retinoid-X-Receptor (RXR) Selective Agonists Than Bexarotene.
Jurutka PW; di Martino O; Reshi S; Mallick S; Sausedo MA; Moen GA; Lee IJ; Ivan DJ; Krall TD; Peoples SJ; Perez A; Tromba L; Le A; Khadka I; Petros R; Savage BM; Salama E; Salama J; Ziller JW; Noh Y; Lee MY; Liu W; Welch JS; Marshall PA; Wagner CE
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555852
[TBL] [Abstract] [Full Text] [Related]
4. Cinobufagin induces acute promyelocytic leukaemia cell apoptosis and PML-rara degradation in a caspase-dependent manner by inhibiting the β-catenin signalling pathway.
Bian Y; Xue M; Guo X; Jiang W; Zhao Y; Zhang Z; Wang X; Hu Y; Zhang Q; Dun W; Zhang L
Pharm Biol; 2022 Dec; 60(1):1801-1811. PubMed ID: 36121296
[TBL] [Abstract] [Full Text] [Related]
5. Clinicopathological Evaluation of Acute Leukemias in a Tertiary Care Hospital: A Cross-Sectional Study.
Patel GN; Gudur R; Gudur A; Oswal RM; Kanethkar S
Turk Patoloji Derg; 2021; 37(2):145-153. PubMed ID: 33973643
[TBL] [Abstract] [Full Text] [Related]
6. Gene of the month:
Nathany S; Tripathi R; Mehta A
J Clin Pathol; 2021 Jan; 74(1):1-4. PubMed ID: 32907914
[TBL] [Abstract] [Full Text] [Related]
7. Fertility in female cancer survivors: a systematic review and meta-analysis.
Busnelli A; Vitagliano A; Mensi L; Acerboni S; Bulfoni A; Filippi F; Somigliana E
Reprod Biomed Online; 2020 Jul; 41(1):96-112. PubMed ID: 32456969
[TBL] [Abstract] [Full Text] [Related]
8. Monotherapy and combination therapy with acitretin for mycosis fungoides: results of a retrospective, multicentre study.
Nikolaou V; Patsatsi A; Sidiropoulou P; Chlouverakis G; Kavvalou E; Koletsa T; Economidi A; Georgiou E; Papadavid E; Rigopoulos D; Stratigos AJ; Kruger-Krasagakis SE
J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):2534-2540. PubMed ID: 32364303
[TBL] [Abstract] [Full Text] [Related]
9. Methods to Generate an Array of Novel Rexinoids by SAR on a Potent Retinoid X Receptor Agonist: A Case Study with NEt-TMN.
Wagner CE; Jurutka PW
Methods Mol Biol; 2019; 2019():109-121. PubMed ID: 31359392
[TBL] [Abstract] [Full Text] [Related]
10. Methods to Assess Activity and Potency of Rexinoids Using Rapid Luciferase-Based Assays: A Case Study with NEt-TMN.
Jurutka PW; Wagner CE
Methods Mol Biol; 2019; 2019():95-108. PubMed ID: 31359391
[TBL] [Abstract] [Full Text] [Related]
11. Molecular profiling of adult acute myeloid and lymphoid leukemia in a major referral center in Lebanon: a 10-year experience report and review of the literature.
Assaf N; El-Cheikh J; Bazarbachi A; Salem Z; Farra C; Chakhachiro Z; Nassif S; Zaatari G; Mahfouz R
Mol Biol Rep; 2019 Apr; 46(2):2003-2011. PubMed ID: 30701458
[TBL] [Abstract] [Full Text] [Related]
12. Long-term effect of all-trans retinoic acid and arsenic trioxide sequential maintenance in patients with acute promyelocytic leukemia.
Tao S; Wang C; Chen Y; Deng Y; Song L; Shi Y; Ling L; Ding B; He Z; Yu L
Leuk Lymphoma; 2019 Mar; 60(3):711-719. PubMed ID: 30407095
[TBL] [Abstract] [Full Text] [Related]
13. Effects of 9-cis-retinoic acid on the proliferation and apoptosis of cutaneous T-cell lymphoma cells.
Yang H; Tao Y; Zhang M; Ma P; Li L; Diao Q
Anticancer Drugs; 2019 Jan; 30(1):56-64. PubMed ID: 30198914
[TBL] [Abstract] [Full Text] [Related]
14. Retinoic acid receptor agonist as monotherapy for early-stage mycosis fungoides: does it work?
Amitay-Laish I; Reiter O; Prag-Naveh H; Kershenovich R; Hodak E
J Dermatolog Treat; 2019 May; 30(3):258-263. PubMed ID: 29889596
[TBL] [Abstract] [Full Text] [Related]
15. ECPIRM, a Potential Therapeutic Agent for Cutaneous T-Cell lymphoma, Inhibits Cell Proliferation and Promotes Apoptosis via a JAK/STAT Pathway.
Yang H; Ma P; Cao Y; Zhang M; Li L; Wei J; Tao L; Qian K
Anticancer Agents Med Chem; 2018; 18(3):401-411. PubMed ID: 28356009
[TBL] [Abstract] [Full Text] [Related]
16. Natural and Structure-based RXR Ligand Scaffolds and Their Functions.
Dominguez M; Alvarez S; de Lera AR
Curr Top Med Chem; 2017; 17(6):631-662. PubMed ID: 27320335
[TBL] [Abstract] [Full Text] [Related]
17. Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trial.
Iland HJ; Collins M; Bradstock K; Supple SG; Catalano A; Hertzberg M; Browett P; Grigg A; Firkin F; Campbell LJ; Hugman A; Reynolds J; Di Iulio J; Tiley C; Taylor K; Filshie R; Seldon M; Taper J; Szer J; Moore J; Bashford J; Seymour JF;
Lancet Haematol; 2015 Sep; 2(9):e357-66. PubMed ID: 26685769
[TBL] [Abstract] [Full Text] [Related]
18. Combination of retinoid and histone deacetylase inhibitor produced an anti-tumor effect in cutaneous T-cell lymphoma by restoring tumor suppressor gene, retinoic acid receptorβ2, via histone acetylation.
Kato Y; Egusa C; Maeda T; Tsuboi R
J Dermatol Sci; 2016 Jan; 81(1):17-25. PubMed ID: 26596218
[TBL] [Abstract] [Full Text] [Related]
19. Modulation of Retinoic Acid Receptor Subtypes by 5- and 8-Substituted (Naphthalen-2-yl)-based Arotinoids.
Álvarez S; Lieb M; Martínez C; Khanwalkar H; Rodríguez-Barrios F; Álvarez R; Gronemeyer H; de Lera AR
ChemMedChem; 2015 Aug; 10(8):1378-91. PubMed ID: 26012882
[TBL] [Abstract] [Full Text] [Related]
20. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
[TBL] [Abstract] [Full Text] [Related]
[Next]
